|1.||Tranter, Robert S: 4 articles (04/2014 - 07/2009)|
|2.||Yang, Xueliang: 3 articles (06/2013 - 07/2009)|
|3.||Puska, P M: 3 articles (07/2007 - 04/2001)|
|4.||He, Shou-zhi: 3 articles (08/2004 - 05/2003)|
|5.||Zhao, Shi-hong: 3 articles (08/2004 - 05/2003)|
|6.||Annesley, Christopher J: 2 articles (04/2014 - 06/2013)|
|7.||Tranter, R S: 2 articles (03/2011 - 01/2004)|
|8.||Kiefer, J H: 2 articles (03/2011 - 01/2004)|
|9.||Chen, Yung-Jen: 2 articles (12/2004 - 11/2004)|
|10.||Shi, Xue-hui: 2 articles (08/2004 - 06/2004)|
|1.||Diabetic Retinopathy (Retinopathy, Diabetic)
07/01/1995 - "The therapeutic efficacy of the continuous wave (CW) Nd:YAG laser (working in the free running mode) was investigated in proliferative diabetic retinopathy (PDR) comparing it with a conventional laser source such as the krypton laser. "
01/01/1982 - "A similar clinical trial to compare the efficacy of krypton laser to the proven efficacy of argon laser in the treatment of proliferative diabetic retinopathy is still anticipated."
06/01/1979 - "A comparative study of the relative efficacy of the krypton and argon lasers in the treatment of disc new vessels in diabetic retinopathy was made. "
10/01/1988 - "Krypton laser for proliferative diabetic retinopathy: the Krypton Argon Regression of Neovascularization Study."
11/01/1993 - "The Krypton Argon Regression of Neovascularization Study (KARNS) was designed to compare the efficacy of red krypton versus blue-green argon laser photocoagulation for the management of high-risk proliferative diabetic retinopathy. "
01/01/2014 - "An experimental study on choroidal neovascularization induced by Krypton laser in rat model."
05/01/2003 - "[Study on the experimental model of krypton laser-induced choroidal neovascularization in the rats]."
04/01/1994 - "To summarize findings from three randomized clinical trials of krypton laser treatment of juxtafoveal neovascular lesions regarding changes in visual acuity during 5 years of follow-up, rates of persistent and recurrent choroidal neovascularization, and status of macular lesions 5 years after enrollment. "
10/01/2009 - "To evaluate the influence of Chinese drugs for cooling blood and dissolving stasis (CBDS) in different concentrations on morphology of krypton laser induced choroidal neovascularization (CNV) in brown Norway (BN) rats. "
12/01/2004 - "Seventeen eyes of 17 cases, aged 50 - 74 years (averaged 60.8 years) with mainly subfoveal classic choroidal neovascularization were treated with krypton laser at lower power setting. "
|3.||Macular Degeneration (Age-Related Maculopathy)
06/01/1984 - "[Krypton laser in the treatment of subretinal neovessels in senile macular degeneration. "
05/01/1984 - "[Treatment of exudative hemorrhagic macular degenerations with the krypton laser]."
09/01/1980 - "Krypton laser in the management of disciform macular degeneration."
06/01/1990 - "The 247 eyes assigned to krypton red laser photocoagulation in the Age-Related Macular Degeneration Study-Krypton Laser were examined to describe the incidence, timing, visual impact, and potential risk factors for persistence and recurrence. "
05/01/1991 - "Krypton Laser photocoagulation for neovascular lesions of age-related macular degeneration."
02/01/1995 - "Among eyes in the Ocular Histoplasmosis Study--Krypton Laser with lesions less than 200 microns from the center of the foveal avascular zone, only 5% of eyes with laser treatment that covered the foveal side and had a narrow (< or = 100 microns) border of treatment to adjacent uninvolved retina experienced severe visual acuity loss compared with approximately 25% of eyes with either some of the foveal side of the lesion left untreated or a wide border of treatment on the foveal side. "
02/01/1981 - "Treatment of macular subretinal neovascularization with the red-light krypton laser in presumed ocular histoplasmosis syndrome."
03/01/1989 - "The 144 eyes assigned to krypton red laser photocoagulation in the Ocular Histoplasmosis Study-Krypton Laser were examined to describe persistence and recurrence in these patients. "
03/01/1989 - "Persistent and recurrent neovascularization after krypton laser photocoagulation for neovascular lesions of ocular histoplasmosis. "
11/01/1987 - "Krypton laser photocoagulation for neovascular lesions of ocular histoplasmosis. "
11/01/2004 - "Vision was improved within 2 weeks after surgery in all eyes with premacular hemorrhage, which received krypton laser membranotomy. "
12/01/2004 - "We performed a study to evaluate the safety and effectiveness of krypton laser membranotomy in selected cases of premacular hemorrhage. "
12/01/2004 - "Krypton laser membranotomy appears to be a safe and simple alternative procedure for treating selected cases of premacular hemorrhage. "
12/01/2004 - "Krypton laser was used to create a membranotomy on the sloping edge of the premacular hemorrhage. "
12/01/2004 - "Krypton laser membranotomy in the treatment of dense premacular hemorrhage."
|5.||Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
|6.||Pentetic Acid (DTPA)